Search results
Results from the WOW.Com Content Network
Risankizumab, sold under the brand name Skyrizi (/ s k aɪ ˈ r ɪ z i / sky-RIZZ-ee), is a humanized monoclonal antibody used for the treatment of plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis. [6] [7] It is designed to target interleukin 23A (IL-23A). [6] [7] [9] It is given by subcutaneous injection. [6] [7]
Skyrizi total sales were nearly $3.8 billion, reflecting operational growth of 57.9%. Rinvoq total sales were more than $1.8 billion, reflecting operational growth of 47.1%.
Humira net revenues decreased 48.7% on an operational basis to $1.682 billion, Skyrizi net revenues rose 57.9% to $3.778 billion, and Rinvoq revenues gained 47.1% to $1.834 billion.
Therapeutic, diagnostic and preventive monoclonal antibodies are clones of a single parent cell. When used as drugs, the International Nonproprietary Names (INNs) end in -mab.
Skyrizi sales of $2.01 billion beat estimates of $1.94 billion, while Rinvoq's $1.09 billion came in slightly higher than expectations of $1.06 billion.
Mattsson (left) as "Betty-Sue" in Wild Side Story in Stockholm in 2002. Helena Mattsson (born March 30, 1984) is a Swedish-American actress. She began her career appearing in Swedish stage productions before moving to United States.
The stock rallied sharply following a better-than-expected fourth-quarter earnings report, propelled by strong sales of blockbuster autoimmune drugs Skyrizi and Rinvoq -- seen as improved ...
Cyrina Fiallo was born in Miami, Florida and is of Cuban and Italian descent. [2] [3] Fiallo is best known for her recurring role as Vonnie on the Disney Channel sitcom Good Luck Charlie.